ArticleScientific reports2021

Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy.

Ahmet Bilgehan Şahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.